TNGX — Tango Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Tango Therapeutics, fiscal year end - December 31st, millions except per share.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:		10-K	10-K	10-K	10-K
Standards:	—	USG	USG	USG	USG
Status:	fx Preliminary	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	—	1.31	485	366	337
Net Total Accounts Receivable
Net Total Receivables	—	—	2	2	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	—	1.5	492	375	347
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	6.09	57.8	53.4
Long Term Investments
Other Long Term Assets
Total Assets	—	168	500	436	403
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	—	0.114	40.7	55.5	45.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	—	5.95	155	187	149
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	—	162	345	249	253
Total Liabilities & Shareholders' Equity	—	168	500	436	403
Total Common Shares Outstanding